Pakistan · Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 4.10 billion. The enterprise value is 4.46 billion.
| Market Cap | 4.10B |
| Enterprise Value | 4.46B |
Important Dates
The last earnings date was Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 98.53 million shares outstanding.
| Current Share Class | 98.53M |
| Shares Outstanding | 98.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.42% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 6.51% |
| Float | 26.78M |
Valuation Ratios
The trailing PE ratio is 19.15.
| PE Ratio | 19.15 |
| Forward PE | n/a |
| PS Ratio | 0.97 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of -196.29.
| EV / Earnings | 20.86 |
| EV / Sales | 1.06 |
| EV / EBITDA | 9.63 |
| EV / EBIT | 9.83 |
| EV / FCF | -196.29 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.95 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.98 |
| Debt / FCF | -19.90 |
| Interest Coverage | 9.81 |
Financial Efficiency
Return on equity (ROE) is 9.21% and return on invested capital (ROIC) is 8.53%.
| Return on Equity (ROE) | 9.21% |
| Return on Assets (ROA) | 7.24% |
| Return on Invested Capital (ROIC) | 8.53% |
| Return on Capital Employed (ROCE) | 18.55% |
| Weighted Average Cost of Capital (WACC) | 5.89% |
| Revenue Per Employee | 18.83M |
| Profits Per Employee | 955,080 |
| Employee Count | 224 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, IBL HealthCare has paid 191.05 million in taxes.
| Income Tax | 191.05M |
| Effective Tax Rate | 47.17% |
Stock Price Statistics
The stock price has increased by +28.64% in the last 52 weeks. The beta is 0.31, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +28.64% |
| 50-Day Moving Average | 55.54 |
| 200-Day Moving Average | 54.91 |
| Relative Strength Index (RSI) | 35.79 |
| Average Volume (20 Days) | 138,891 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.22 billion and earned 213.94 million in profits. Earnings per share was 2.17.
| Revenue | 4.22B |
| Gross Profit | 1.57B |
| Operating Income | 453.84M |
| Pretax Income | 404.99M |
| Net Income | 213.94M |
| EBITDA | 458.78M |
| EBIT | 453.84M |
| Earnings Per Share (EPS) | 2.17 |
Balance Sheet
The company has 87.62 million in cash and 452.47 million in debt, with a net cash position of -364.85 million or -3.70 per share.
| Cash & Cash Equivalents | 87.62M |
| Total Debt | 452.47M |
| Net Cash | -364.85M |
| Net Cash Per Share | -3.70 |
| Equity (Book Value) | 2.43B |
| Book Value Per Share | 24.65 |
| Working Capital | 1.80B |
Cash Flow
In the last 12 months, operating cash flow was -477,000 and capital expenditures -22.26 million, giving a free cash flow of -22.73 million.
| Operating Cash Flow | -477,000 |
| Capital Expenditures | -22.26M |
| Free Cash Flow | -22.73M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 37.25%, with operating and profit margins of 10.76% and 5.07%.
| Gross Margin | 37.25% |
| Operating Margin | 10.76% |
| Pretax Margin | 9.60% |
| Profit Margin | 5.07% |
| EBITDA Margin | 10.88% |
| EBIT Margin | 10.76% |
| FCF Margin | n/a |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.01% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 5.22% |
| FCF Yield | -0.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 7, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Oct 7, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
IBL HealthCare has an Altman Z-Score of 3.68 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.68 |
| Piotroski F-Score | 4 |